HRI scientist leading the world in blood vessel regrowth

Zoe Clayton joined The HRI as a research assistant, working for Dr. Sanjay Patel and Associate Prof. Martin Ng in the Translational Research Group.  Zoe completed her Masters degrees (BSc/MSc - Honours) in Physiology and is currently completing her PhD here at the Institute. Zoe is currently a member of the Cell Therapeutics Group, led by Dr Sanjay Patel. 

I’m investigating the ability of certain novel cell types to promote new blood vessel growth (angiogenesis) in cardiovascular disease settings,” she says.

“My biggest aim at the moment is to successfully complete my PhD and hopefully demonstrate that the cell types I’m working with have therapeutic potential. At this stage, my longer-term goal is to stay in research and pursue a post-doctoral fellowship after finishing my PhD. Ideally something in the stem cell field or in the regulation of angiogenesis/strategies for achieving therapeutic angiogenesis,” she says.

“To anybody already donating to The Heart Research Institute I would say a very big thank you,” says Zoe.

“The donations make a huge difference. They’ve provided us with excellent facilities, consumables and equipment, so we have access to the resources we need to do great research in a timely manner. Donations also help young/early career scientists to get started in research and allow us to work on projects that we wouldn’t otherwise be able to pursue”.

Previous
Next

Related news

Scientific minds coming together

HRI researchers Dr Mary Kavurma, Associate Professor Simone Schoenwaelder, Dr Amelia Tomkins and Bradley Tucker attended the ANZMS and AVBS Conference 2017 to share and discuss the latest research in the field.
Read more

Glowing Stem Cells Mend Broken Hearts

HRI researcher is heralding hope for broken hearts with a cutting-edge tool that helps scientists fast-track exciting new therapies to mend damaged organs.

Richard Tan from the Heart Research Institute in Sydney has developed a glowing stem cell tracker model that could change the way the science community develops life-saving tissue therapies.

Read more

HRI shows drug suppresses heart vessel inflammation

In a world-first discovery, scientists at The Heart Research Institute (HRI) and collaborators have shown the anti-inflammatory drug colchicine dramatically reduces local cardiac inflammation when used shortly before cardiac catheterisation. 

Read more